Clinical Trial Update: A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the pharmacodynamic properties of NN5401 in subjects with Type 1 diabetes mellitus; the study sponsored by Novo Nordisk A/S is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NN5401

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED